#pipelinenews kết quả tìm kiếm

GMONAD BROTHERS Today I invite you to join @pipeline_xyz on Twitch You can win various prizes, from NFT to a car, I'm not kidding, let's have fun together this Thursday💜💜 #monad #pipelinenews

gremlin_crypto1's tweet image. GMONAD BROTHERS

Today I invite you to join @pipeline_xyz  on Twitch

You can win various prizes, from NFT to a car, I'm not kidding, let's have fun together this Thursday💜💜

#monad #pipelinenews

A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis. Find out more: hcplive.com/view/risankizu… #Dermatology #PipelineNews

HCPLiveNews's tweet image. A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis.

Find out more: hcplive.com/view/risankizu…

#Dermatology #PipelineNews

ICYMI: Data from REDEFINE 1 found CagriSema achieved a superior weight loss of 22.7% vs. placebo after 68 weeks of treatment in adults with obesity or overweight. 🔗 hcplive.com/view/cagrisema… #Obesity #PipelineNews

HCPLiveNews's tweet image. ICYMI:

Data from REDEFINE 1 found CagriSema achieved a superior weight loss of 22.7%  vs. placebo after 68 weeks of treatment in adults with obesity or overweight.

🔗 hcplive.com/view/cagrisema…

#Obesity #PipelineNews

Topline data from REDEFINE 1 found CagriSema, a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved superior weight loss versus placebo in adults with obesity or overweight. 🔗hcplive.com/view/cagrisema… #ObesityManagement #PipelineNews

HCPLiveNews's tweet image. Topline data from REDEFINE 1 found CagriSema, a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved superior weight loss versus placebo in adults with obesity or overweight.

🔗hcplive.com/view/cagrisema…

#ObesityManagement #PipelineNews

OCS-05, an investigational neuroprotective therapy for acute optic neuritis, met its key primary safety endpoint and achieved statistical significance on efficacy-based secondary endpoints in the Phase 2 ACUITY trial. 🔗hcplive.com/view/ocs-05-fo… #Ophthalmology #PipelineNews

HCPLiveNews's tweet image. OCS-05, an investigational neuroprotective therapy for acute optic neuritis, met its key primary safety endpoint and achieved statistical significance on efficacy-based secondary endpoints in the Phase 2 ACUITY trial.

🔗hcplive.com/view/ocs-05-fo… 

#Ophthalmology #PipelineNews

The Canada Energy Regulator (CER) said on Monday it has approved Trans Mountain’s request to pause the regulatory process for its interim tolls application. #OilNews #transmountain #pipelinenews #pipeline #EnergyNews energynow.ca/2025/10/canada…


It may have taken a decade, but Canada’s Asia Pacific Gateway now has two new pipelines providing egress for Canadian oil and natural gas to Asia. #pipelinenews #OilNews #oilandgas energynow.ca/2025/08/new-pi…


$8.9B Carbon Pipeline in Jeopardy 200+ lawsuits filed as SD bans eminent domain for CO2 pipelines—threatening Summit Carbon’s 2,500-mile project. Clean energy or land rights clash? #CarbonCapture #LandRights #PipelineNews #CleanEnergyDebate apnews.com/article/summit…


Announced by @NovoNordisk, topline results from the Phase 3b STEP UP trial demonstrated statistically significant and superior weight loss at 72 weeks with semaglutide 7.2 mg, compared with placebo, irrespective of treatment adherence. 🔗hcplive.com/view/semagluti… #PipelineNews


Pipeline Politics or Progress? After more than a decade of delays, the Constitution Pipeline might finally have a green light — thanks to what some are calling a political trade-off between President Trump and New York Governor Kathy Hochul. #EnergyPolicy #PipelineNews #NSEP


Pipeline Politics or Progress? After more than a decade of delays, the Constitution Pipeline might finally have a green light — thanks to what some are calling a political trade-off between President Trump and New York Governor Kathy Hochul. #EnergyPolicy #PipelineNews #NSEP


The Canada Energy Regulator (CER) said on Monday it has approved Trans Mountain’s request to pause the regulatory process for its interim tolls application. #OilNews #transmountain #pipelinenews #pipeline #EnergyNews energynow.ca/2025/10/canada…


It may have taken a decade, but Canada’s Asia Pacific Gateway now has two new pipelines providing egress for Canadian oil and natural gas to Asia. #pipelinenews #OilNews #oilandgas energynow.ca/2025/08/new-pi…


GMONAD BROTHERS Today I invite you to join @pipeline_xyz on Twitch You can win various prizes, from NFT to a car, I'm not kidding, let's have fun together this Thursday💜💜 #monad #pipelinenews

gremlin_crypto1's tweet image. GMONAD BROTHERS

Today I invite you to join @pipeline_xyz  on Twitch

You can win various prizes, from NFT to a car, I'm not kidding, let's have fun together this Thursday💜💜

#monad #pipelinenews

Pipeline Politics or Progress? After more than a decade of delays, the Constitution Pipeline might finally have a green light — thanks to what some are calling a political trade-off between President Trump and New York Governor Kathy Hochul. #EnergyPolicy #PipelineNews #NSEP


Pipeline Politics or Progress? After more than a decade of delays, the Constitution Pipeline might finally have a green light — thanks to what some are calling a political trade-off between President Trump and New York Governor Kathy Hochul. #EnergyPolicy #PipelineNews #NSEP


Pipeline Politics or Progress? After more than a decade of delays, the Constitution Pipeline might finally have a green light — thanks to what some are calling a political trade-off between President Trump and New York Governor Kathy Hochul. #EnergyPolicy #PipelineNews #NSEP


Announced by @NovoNordisk, topline results from the Phase 3b STEP UP trial demonstrated statistically significant and superior weight loss at 72 weeks with semaglutide 7.2 mg, compared with placebo, irrespective of treatment adherence. 🔗hcplive.com/view/semagluti… #PipelineNews


OCS-05, an investigational neuroprotective therapy for acute optic neuritis, met its key primary safety endpoint and achieved statistical significance on efficacy-based secondary endpoints in the Phase 2 ACUITY trial. 🔗hcplive.com/view/ocs-05-fo… #Ophthalmology #PipelineNews

HCPLiveNews's tweet image. OCS-05, an investigational neuroprotective therapy for acute optic neuritis, met its key primary safety endpoint and achieved statistical significance on efficacy-based secondary endpoints in the Phase 2 ACUITY trial.

🔗hcplive.com/view/ocs-05-fo… 

#Ophthalmology #PipelineNews

ICYMI: Data from REDEFINE 1 found CagriSema achieved a superior weight loss of 22.7% vs. placebo after 68 weeks of treatment in adults with obesity or overweight. 🔗 hcplive.com/view/cagrisema… #Obesity #PipelineNews

HCPLiveNews's tweet image. ICYMI:

Data from REDEFINE 1 found CagriSema achieved a superior weight loss of 22.7%  vs. placebo after 68 weeks of treatment in adults with obesity or overweight.

🔗 hcplive.com/view/cagrisema…

#Obesity #PipelineNews

Topline data from REDEFINE 1 found CagriSema, a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved superior weight loss versus placebo in adults with obesity or overweight. 🔗hcplive.com/view/cagrisema… #ObesityManagement #PipelineNews

HCPLiveNews's tweet image. Topline data from REDEFINE 1 found CagriSema, a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved superior weight loss versus placebo in adults with obesity or overweight.

🔗hcplive.com/view/cagrisema…

#ObesityManagement #PipelineNews

A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis. Find out more: hcplive.com/view/risankizu… #Dermatology #PipelineNews

HCPLiveNews's tweet image. A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis.

Find out more: hcplive.com/view/risankizu…

#Dermatology #PipelineNews

A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis. Find out more: hcplive.com/view/risankizu… #Dermatology #PipelineNews

HCPLiveNews's tweet image. A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis.

Find out more: hcplive.com/view/risankizu…

#Dermatology #PipelineNews

Iowa Republican Lawmakers to Challenge Approval of Controversial Carbon Pipeline in Court #pipelinejournal #pipelinenews #pipelineindustry #pipelines pipeline-journal.net/news/iowa-repu…


#PipelineNews: @realDonaldTrump Infrastructure Plan Would Greatly Reduce Oversight of Pipelines, National Parks: A Proposal to Scale Back Environmental Requirements Has Been Drafted...▼ chicagotribune.com/news/nationwor…

hobodreamer's tweet image. #PipelineNews: @realDonaldTrump Infrastructure Plan Would Greatly Reduce Oversight of Pipelines, National Parks: A Proposal to Scale Back Environmental Requirements Has Been Drafted...▼ chicagotribune.com/news/nationwor…

GMONAD BROTHERS Today I invite you to join @pipeline_xyz on Twitch You can win various prizes, from NFT to a car, I'm not kidding, let's have fun together this Thursday💜💜 #monad #pipelinenews

gremlin_crypto1's tweet image. GMONAD BROTHERS

Today I invite you to join @pipeline_xyz  on Twitch

You can win various prizes, from NFT to a car, I'm not kidding, let's have fun together this Thursday💜💜

#monad #pipelinenews

A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis. Find out more: hcplive.com/view/risankizu… #Dermatology #PipelineNews

HCPLiveNews's tweet image. A matching-adjusted indirect comparison (MAIC) analysis found risankizumab achieved greater skin clearance versus deucravacitinib for moderate-to-severe plaque psoriasis.

Find out more: hcplive.com/view/risankizu…

#Dermatology #PipelineNews

ICYMI: Data from REDEFINE 1 found CagriSema achieved a superior weight loss of 22.7% vs. placebo after 68 weeks of treatment in adults with obesity or overweight. 🔗 hcplive.com/view/cagrisema… #Obesity #PipelineNews

HCPLiveNews's tweet image. ICYMI:

Data from REDEFINE 1 found CagriSema achieved a superior weight loss of 22.7%  vs. placebo after 68 weeks of treatment in adults with obesity or overweight.

🔗 hcplive.com/view/cagrisema…

#Obesity #PipelineNews

Topline data from REDEFINE 1 found CagriSema, a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved superior weight loss versus placebo in adults with obesity or overweight. 🔗hcplive.com/view/cagrisema… #ObesityManagement #PipelineNews

HCPLiveNews's tweet image. Topline data from REDEFINE 1 found CagriSema, a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved superior weight loss versus placebo in adults with obesity or overweight.

🔗hcplive.com/view/cagrisema…

#ObesityManagement #PipelineNews

The first Pipeline Technology Journal (ptj) in 2022 is out now! With technical articles from @rosen_group, @InteroIntegrity, @bakerhughesco, @saudi_aramco, TRAPIL & @AtmosInt Read online ▶️pipeline-journal.net/journal/pipeli… #pipelines #pipelinejournal #pipelinenews #newissue

pipelinejournal's tweet image. The first Pipeline Technology Journal (ptj) in 2022 is out now! 

With technical articles from @rosen_group, @InteroIntegrity, @bakerhughesco, @saudi_aramco, TRAPIL & @AtmosInt    
  
Read online ▶️pipeline-journal.net/journal/pipeli…

#pipelines #pipelinejournal #pipelinenews #newissue

The 3rd Pipeline Technology Journal (ptj) in 2023 is out now! Featuring 7 papers from 8 companies, including @aramco, @Siemens, @SpeirHunterLtd, @OrbitalSidekick, @NdtSkipper & @GRTgaz Read online ▶️ pipeline-journal.net/journal/pipeli… #pipelines #pipelinejournal #pipelinenews #newissue

pipelinejournal's tweet image. The 3rd Pipeline Technology Journal (ptj) in 2023 is out now!

Featuring 7 papers from 8 companies, including @aramco, @Siemens, @SpeirHunterLtd, @OrbitalSidekick, @NdtSkipper & @GRTgaz

Read online ▶️ pipeline-journal.net/journal/pipeli…

#pipelines #pipelinejournal #pipelinenews #newissue

OCS-05, an investigational neuroprotective therapy for acute optic neuritis, met its key primary safety endpoint and achieved statistical significance on efficacy-based secondary endpoints in the Phase 2 ACUITY trial. 🔗hcplive.com/view/ocs-05-fo… #Ophthalmology #PipelineNews

HCPLiveNews's tweet image. OCS-05, an investigational neuroprotective therapy for acute optic neuritis, met its key primary safety endpoint and achieved statistical significance on efficacy-based secondary endpoints in the Phase 2 ACUITY trial.

🔗hcplive.com/view/ocs-05-fo… 

#Ophthalmology #PipelineNews

#PipelineNews 𝙄𝙡 𝙥𝙤𝙧𝙩𝙖𝙡𝙚 𝙞𝙩𝙖𝙡𝙞𝙖𝙣𝙤 𝙙𝙚𝙙𝙞𝙘𝙖𝙩𝙤 𝙖𝙡𝙡’𝙞𝙣𝙛𝙤𝙧𝙢𝙖𝙯𝙞𝙤𝙣𝙚 𝙙𝙚𝙜𝙡𝙞 𝙤𝙥𝙚𝙧𝙖𝙩𝙤𝙧𝙞 𝙙𝙚𝙡 𝙘𝙤𝙢𝙥𝙖𝙧𝙩𝙤 𝙙𝙚𝙡 𝙈𝙄𝘿𝙎𝙏𝙍𝙀𝘼𝙈 🔻Portale informativo della fiera @2024Pge

PlnNews's tweet image. #PipelineNews

𝙄𝙡 𝙥𝙤𝙧𝙩𝙖𝙡𝙚 𝙞𝙩𝙖𝙡𝙞𝙖𝙣𝙤 𝙙𝙚𝙙𝙞𝙘𝙖𝙩𝙤 𝙖𝙡𝙡’𝙞𝙣𝙛𝙤𝙧𝙢𝙖𝙯𝙞𝙤𝙣𝙚 𝙙𝙚𝙜𝙡𝙞 𝙤𝙥𝙚𝙧𝙖𝙩𝙤𝙧𝙞
𝙙𝙚𝙡 𝙘𝙤𝙢𝙥𝙖𝙧𝙩𝙤 𝙙𝙚𝙡 𝙈𝙄𝘿𝙎𝙏𝙍𝙀𝘼𝙈
 
🔻Portale informativo della fiera @2024Pge

#PipelineNews: Trumps Infrastructure Plan Would Greatly Reduce Oversight of Pipelines, National Parks: A Proposal to Scale Back Environmental Requirements Has Been Drafted...▼ chicagotribune.com/news/nationwor…

SeaShepherdPaul's tweet image. #PipelineNews: Trumps Infrastructure Plan Would Greatly Reduce Oversight of Pipelines, National Parks: A Proposal to Scale Back Environmental Requirements Has Been Drafted...▼ chicagotribune.com/news/nationwor…

Joint venture to build crude connector system in Midland Basin #pipeline #pipelinenews #oilandgas buff.ly/2IRd8pg

JL_PenleighInt's tweet image. Joint venture to build crude connector system in Midland Basin #pipeline #pipelinenews #oilandgas buff.ly/2IRd8pg

E’ uscita la 𝗣𝗶𝗽𝗲𝗹𝗶𝗻𝗲𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗻° 𝗦𝗲𝘁𝘁𝗲𝗺𝗯𝗿𝗲 Iscriviti alla #Newsletter e richiedi ℹ️ sulla pubblicità! 📩[email protected] #PipelineNews #website #pipeline #midstream #oilandgas #oil #gas #water

PlnNews's tweet image. E’ uscita la 𝗣𝗶𝗽𝗲𝗹𝗶𝗻𝗲𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗻° 𝗦𝗲𝘁𝘁𝗲𝗺𝗯𝗿𝗲
Iscriviti alla #Newsletter e richiedi ℹ️ sulla pubblicità!

📩info@pipelinenews.it

#PipelineNews #website  #pipeline #midstream #oilandgas #oil #gas #water

La Casa Editrice e la Redazione di #PipelineNews vi augurano un 𝙨𝙚𝙧𝙚𝙣𝙤 𝙉𝙖𝙩𝙖𝙡𝙚 𝙚𝙙 𝙪𝙣 𝙛𝙚𝙡𝙞𝙘𝙚 𝙖𝙣𝙣𝙤 𝙣𝙪𝙤𝙫𝙤 #PipelineNews #website #pipeline #midstream #oilandgas #oil #gas #water

PlnNews's tweet image. La Casa Editrice e la Redazione di #PipelineNews vi augurano un 𝙨𝙚𝙧𝙚𝙣𝙤 𝙉𝙖𝙩𝙖𝙡𝙚 𝙚𝙙 𝙪𝙣 𝙛𝙚𝙡𝙞𝙘𝙚 𝙖𝙣𝙣𝙤 𝙣𝙪𝙤𝙫𝙤

#PipelineNews #website  #pipeline #midstream #oilandgas #oil #gas #water

📢 The 1st Pipeline Technology Journal (ptj) in 2024 is out now! Read online ▶️ pipeline-journal.net/journal/pipeli… #pipelines #pipelinejournal #pipelinenews #newissue

pipelinejournal's tweet image. 📢 The 1st Pipeline Technology Journal (ptj) in 2024 is out now!

Read online ▶️ pipeline-journal.net/journal/pipeli…

#pipelines #pipelinejournal #pipelinenews #newissue

North American Pipeline Project Roundup: April 2019 #pipeline #pipelinenews #oilandgas buff.ly/2vhq3J9

JL_PenleighInt's tweet image. North American Pipeline Project Roundup: April 2019 #pipeline #pipelinenews #oilandgas buff.ly/2vhq3J9

Loading...

Something went wrong.


Something went wrong.


United States Trends